The trial enrolled patients with stage IV pancreatic cancer, where median life expectancy is just 6 to 12 months
Previously, Arexvy was authorized for adults 60 and older, and for those 50–59 with heightened risk
This study demonstrates the power of real-time glucose information for people with Type 2 diabetes treated with basal insulin
The facility will manufacture the critical antibiotic intermediate Amino Cephalosporanic Acid (ACA), a key component in the production of cephalosporin antibiotics
The new entity will operate with separate resources, funding, and operations, while BioNTech will contribute related rights and mRNA technologies to support its ambitious mission
Neupharma gains exclusive rights to develop and commercialize corticorelin for peritumoral brain edema
The move comes as China rapidly expands its capabilities in the pharmaceutical sector, particularly in licensing and drug development
The biotechnology company will tap into Catalent’s expertise in induced pluripotent stem cells and advanced cell-therapy manufacturing
Salanersen was generally well-tolerated, slowed neurodegeneration, and enabled functional gains
The move comes as the global biotech and biopharma CDMO market continues to surge, fueled by rising demand
Subscribe To Our Newsletter & Stay Updated
